Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H N Sather

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Medical and Pediatric Oncology|July 1, 1996
Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group studyB J Lange, J Blatt, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer GroupL A Mattano, H N Sather, M E Trigg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemiaM E Nesbit, H N Sather, L L Robison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapyK K Matthay, H N Sather, R C Seeger, et al.
Journal of Pediatric Surgery|February 1, 1989
Improvement in survival after excision of primary tumor in stage III neuroblastomaG M Haase, K Y Wong, A A deLorimier, et al.
Cancer|May 1, 1999
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group reportT A Kaleita, G H Reaman, W E MacLean, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer GroupJ Nachman, H N Sather, P S Gaynon, et al.
Human Pathology|October 1, 1988
Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study GroupJ Chatten, H Shimada, H N Sather, et al.
Cancer|April 15, 1980
Testicular relapse in childhood acute lymphoblastic leukemia: association with pretreatment patient characteristics and treatment. A report for Childrens Cancer Study GroupM E Nesbit, L L Robison, J A Ortega, et al.
Journal of Pediatric Hematology/Oncology|August 13, 1999
Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer GroupW R Rackoff, J Ge, H N Sather, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Medical and Pediatric Oncology|July 1, 1996
Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group studyB J Lange, J Blatt, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer GroupL A Mattano, H N Sather, M E Trigg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemiaM E Nesbit, H N Sather, L L Robison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapyK K Matthay, H N Sather, R C Seeger, et al.
Journal of Pediatric Surgery|February 1, 1989
Improvement in survival after excision of primary tumor in stage III neuroblastomaG M Haase, K Y Wong, A A deLorimier, et al.
Cancer|May 1, 1999
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group reportT A Kaleita, G H Reaman, W E MacLean, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer GroupJ Nachman, H N Sather, P S Gaynon, et al.
Human Pathology|October 1, 1988
Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study GroupJ Chatten, H Shimada, H N Sather, et al.
Cancer|April 15, 1980
Testicular relapse in childhood acute lymphoblastic leukemia: association with pretreatment patient characteristics and treatment. A report for Childrens Cancer Study GroupM E Nesbit, L L Robison, J A Ortega, et al.
Journal of Pediatric Hematology/Oncology|August 13, 1999
Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer GroupW R Rackoff, J Ge, H N Sather, et al.
Pageof 9